WETS
LENZ

Wealth Enhancement Trust Services’s LENZ Therapeutics LENZ Stock Holding History

Wealth Enhancement Trust Services’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6 Buy
+1
New +$8 ﹤0.01% 1523

Other funds holding LENZ

VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $46.3B AUM 43.9% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $78.6B AUM 28.08% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Wealth Enhancement Trust Services's LENZ Position: Q2 2026 in Review

Wealth Enhancement Trust Services opened a new position in LENZ Therapeutics (LENZ) in Q2 2026: 1 share worth $6. The stake represents ﹤0.01% of the portfolio and ranks #1523 among its holdings.

65 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • Wealth Enhancement Trust Services held 1 share of LENZ Therapeutics worth $6 as of Q2 2026.
  • LENZ Therapeutics was a new Wealth Enhancement Trust Services position in Q2 2026.
  • LENZ Therapeutics made up ﹤0.01% of Wealth Enhancement Trust Services's portfolio in Q2 2026, its #1523 holding.
  • 65 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q2 2026, filed 15 Jul 2026.